Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-107 ABI3BP 0.24 0.01708 -1.96 0 miRanda -0.49 0.00087 NA
2 hsa-miR-32-3p ABI3BP 0.22 0.20722 -1.96 0 mirMAP -0.44 0 NA
3 hsa-miR-32-5p ABI3BP 0.08 0.54898 -1.96 0 miRNATAP -0.61 0 NA
4 hsa-miR-374a-5p ABI3BP 0.02 0.86978 -1.96 0 mirMAP -0.42 0.00443 NA
5 hsa-miR-421 ABI3BP 0.94 0 -1.96 0 miRanda -0.25 0.00236 NA
6 hsa-miR-590-5p ABI3BP -0.1 0.31003 -1.96 0 miRanda -0.5 0.00064 NA
7 hsa-miR-92a-3p ABI3BP 0.21 0.13429 -1.96 0 miRNATAP -0.29 0.0052 NA
8 hsa-miR-139-5p ADAM12 -2.11 0 0.93 0.0022 miRanda -0.37 0 NA
9 hsa-miR-204-5p ADAM12 -0.54 0.03309 0.93 0.0022 mirMAP -0.39 0 NA
10 hsa-miR-26b-5p ADAM12 -1.11 0 0.93 0.0022 mirMAP; miRNATAP -0.53 2.0E-5 NA
11 hsa-miR-33a-3p ADAM12 -0.68 1.0E-5 0.93 0.0022 mirMAP -0.4 3.0E-5 NA
12 hsa-miR-3607-3p ADAM12 -2.16 0 0.93 0.0022 mirMAP; miRNATAP -0.27 3.0E-5 NA
13 hsa-miR-374a-5p ADAM12 0.02 0.86978 0.93 0.0022 mirMAP -0.48 0.00162 NA
14 hsa-miR-374b-5p ADAM12 -0.31 0.00301 0.93 0.0022 mirMAP -0.57 8.0E-5 NA
15 hsa-miR-155-5p ANPEP 0.01 0.95651 -0.91 0 miRNAWalker2 validate -0.16 0.00051 NA
16 hsa-miR-423-5p ANPEP 0.7 0 -0.91 0 miRNATAP -0.26 0.00246 NA
17 hsa-miR-107 AREG 0.24 0.01708 -1.67 0 miRanda -1.2 0 NA
18 hsa-miR-107 BASP1 0.24 0.01708 -1.8 0 miRanda -0.73 0 NA
19 hsa-miR-193b-3p BASP1 -0.17 0.27202 -1.8 0 miRNAWalker2 validate -0.3 0.00056 NA
20 hsa-miR-33a-3p BASP1 -0.68 1.0E-5 -1.8 0 miRNATAP -0.35 3.0E-5 NA
21 hsa-miR-361-5p BASP1 0.23 0.00962 -1.8 0 miRanda -0.85 0 NA
22 hsa-miR-532-3p BASP1 0.3 0.01463 -1.8 0 PITA -0.58 0 NA
23 hsa-miR-107 BDNF 0.24 0.01708 0.05 0.83189 MirTarget; PITA; miRanda; miRNATAP -0.55 0 27498977 MicroRNA 107 inhibits tumor growth and metastasis by targeting the BDNF mediated PI3K/AKT pathway in human non small lung cancer; In addition BDNF expression was upregulated and inversely correlated with miR-107 in NSCLC tissues; Enforced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-107 on NSCLC proliferation migration and invasion; miR-107 overexpression or downregulation of BDNF was able to inhibit activation of PI3K/AKT signaling pathway; Taken together our findings present the first evidence that miR-107 could suppress NSCLC metastasis by targeting BDNF and indirectly regulating PI3K/AKT signaling pathway which might lead to a potential therapeutic strategy focusing on miR-107 and BDNF for human NSCLC
24 hsa-miR-148a-5p BDNF -0.77 0 0.05 0.83189 mirMAP -0.26 0.00044 NA
25 hsa-miR-192-3p BDNF -0.64 0.00027 0.05 0.83189 MirTarget; miRNATAP -0.32 0 NA
26 hsa-miR-30d-5p BDNF 0.72 0 0.05 0.83189 miRNATAP -0.3 0.00095 NA
27 hsa-miR-589-5p BDNF 1.19 0 0.05 0.83189 miRNATAP -0.24 0.00999 NA
28 hsa-miR-148b-5p BMP1 0.3 0.02557 -0.41 0.00096 mirMAP -0.2 1.0E-5 NA
29 hsa-miR-185-5p BMP1 0.48 0 -0.41 0.00096 mirMAP -0.22 0.00036 NA
30 hsa-miR-339-5p BMP1 0.28 0.03557 -0.41 0.00096 miRanda -0.15 0.00104 NA
31 hsa-miR-484 BMP1 0.09 0.45398 -0.41 0.00096 miRNATAP -0.21 7.0E-5 NA
32 hsa-miR-92a-1-5p BMP1 0.39 0.06449 -0.41 0.00096 mirMAP -0.2 0 NA
33 hsa-miR-10a-5p CADM1 -1.48 0 -0.03 0.88629 MirTarget; miRNATAP -0.13 0.00451 NA
34 hsa-miR-141-3p CADM1 -0.35 0.257 -0.03 0.88629 MirTarget; TargetScan -0.18 0 NA
35 hsa-miR-142-5p CADM1 -1.45 0 -0.03 0.88629 PITA -0.28 0 NA
36 hsa-miR-15b-5p CADM1 0.23 0.08248 -0.03 0.88629 miRNATAP -0.22 0.00084 NA
37 hsa-miR-16-5p CADM1 -0.4 0.0001 -0.03 0.88629 miRNAWalker2 validate; miRTarBase; miRNATAP -0.35 4.0E-5 NA
38 hsa-miR-182-5p CADM1 1.97 0 -0.03 0.88629 miRNATAP -0.11 1.0E-5 24445397 TGF β upregulates miR 182 expression to promote gallbladder cancer metastasis by targeting CADM1; We further identified that the cell adhesion molecule1 CADM1 is a new target gene of miR-182 miR-182 negatively regulates CADM1 expression in vitro and in vivo
39 hsa-miR-200a-3p CADM1 -1.5 3.0E-5 -0.03 0.88629 MirTarget -0.12 0 NA
40 hsa-miR-200b-3p CADM1 -1.29 0.00027 -0.03 0.88629 TargetScan -0.13 0 NA
41 hsa-miR-23a-3p CADM1 -0.18 0.13598 -0.03 0.88629 miRNATAP -0.39 0 NA
42 hsa-miR-27a-3p CADM1 -0.37 0.00876 -0.03 0.88629 MirTarget; miRNATAP -0.39 0 NA
43 hsa-miR-3200-3p CADM1 1.4 0 -0.03 0.88629 MirTarget -0.15 1.0E-5 NA
44 hsa-miR-324-3p CADM1 0.26 0.05061 -0.03 0.88629 PITA -0.34 0 NA
45 hsa-miR-335-3p CADM1 -0.28 0.10663 -0.03 0.88629 mirMAP -0.16 0.00155 NA
46 hsa-miR-338-3p CADM1 0.54 0.00461 -0.03 0.88629 PITA; miRanda -0.2 1.0E-5 NA
47 hsa-miR-342-3p CADM1 -0.32 0.04498 -0.03 0.88629 PITA; miRanda -0.31 0 NA
48 hsa-miR-421 CADM1 0.94 0 -0.03 0.88629 miRanda -0.24 0 NA
49 hsa-miR-424-5p CADM1 -2.63 0 -0.03 0.88629 miRNATAP -0.12 0.00767 NA
50 hsa-miR-429 CADM1 -1.4 7.0E-5 -0.03 0.88629 miRNATAP -0.14 0 NA
51 hsa-miR-484 CADM1 0.09 0.45398 -0.03 0.88629 miRNAWalker2 validate -0.24 0.00163 NA
52 hsa-miR-495-3p CADM1 -0.75 0.00389 -0.03 0.88629 MirTarget -0.12 0.00042 NA
53 hsa-miR-501-3p CADM1 1 0 -0.03 0.88629 PITA; TargetScan -0.18 0.00142 NA
54 hsa-miR-590-5p CADM1 -0.1 0.31003 -0.03 0.88629 PITA; miRanda; miRNATAP -0.34 0.00011 NA
55 hsa-miR-92b-3p CADM1 0.22 0.29619 -0.03 0.88629 miRNATAP -0.34 0 NA
56 hsa-miR-106b-5p CALD1 0.65 0 -0.53 0 miRNATAP -0.31 0 NA
57 hsa-miR-107 CALD1 0.24 0.01708 -0.53 0 miRanda -0.13 0.00459 NA
58 hsa-miR-15a-5p CALD1 0.35 0.00077 -0.53 0 miRNAWalker2 validate -0.17 9.0E-5 NA
59 hsa-miR-16-2-3p CALD1 -0.03 0.80516 -0.53 0 mirMAP -0.16 0 NA
60 hsa-miR-17-5p CALD1 0.7 2.0E-5 -0.53 0 TargetScan; miRNATAP -0.23 0 NA
61 hsa-miR-20a-5p CALD1 0.85 0 -0.53 0 miRNATAP -0.2 0 NA
62 hsa-miR-20b-5p CALD1 0.46 0.02859 -0.53 0 miRNATAP -0.1 0 NA
63 hsa-miR-21-5p CALD1 1.51 0 -0.53 0 miRNAWalker2 validate; MirTarget -0.27 0 NA
64 hsa-miR-32-3p CALD1 0.22 0.20722 -0.53 0 MirTarget -0.12 1.0E-5 NA
65 hsa-miR-338-3p CALD1 0.54 0.00461 -0.53 0 miRanda -0.1 2.0E-5 NA
66 hsa-miR-361-5p CALD1 0.23 0.00962 -0.53 0 miRanda; miRNATAP -0.2 0.00011 NA
67 hsa-miR-421 CALD1 0.94 0 -0.53 0 miRanda -0.18 0 NA
68 hsa-miR-484 CALD1 0.09 0.45398 -0.53 0 PITA -0.14 0.00061 NA
69 hsa-miR-501-3p CALD1 1 0 -0.53 0 TargetScan; miRNATAP -0.14 0 NA
70 hsa-miR-590-5p CALD1 -0.1 0.31003 -0.53 0 miRanda -0.17 0.00031 NA
71 hsa-miR-93-5p CALD1 1.4 0 -0.53 0 miRNATAP -0.23 0 NA
72 hsa-miR-107 CALU 0.24 0.01708 0.32 0.00094 MirTarget; PITA; miRanda -0.16 0.00067 NA
73 hsa-miR-122-5p CALU -1.24 0 0.32 0.00094 miRNAWalker2 validate -0.14 0 NA
74 hsa-miR-125b-2-3p CALU -1.66 0 0.32 0.00094 MirTarget -0.13 0 NA
75 hsa-miR-126-5p CALU -0.43 7.0E-5 0.32 0.00094 MirTarget -0.13 0.00382 NA
76 hsa-miR-23b-3p CALU -0.53 0 0.32 0.00094 mirMAP -0.18 7.0E-5 NA
77 hsa-miR-29c-3p CALU -1.44 0 0.32 0.00094 MirTarget -0.13 1.0E-5 NA
78 hsa-miR-30b-5p CALU -0.54 2.0E-5 0.32 0.00094 MirTarget -0.12 0.00136 NA
79 hsa-miR-30d-3p CALU -0.12 0.32955 0.32 0.00094 MirTarget -0.15 8.0E-5 NA
80 hsa-miR-33a-3p CALU -0.68 1.0E-5 0.32 0.00094 mirMAP -0.12 4.0E-5 NA
81 hsa-miR-125a-3p CAP2 -0.84 4.0E-5 2.07 0 miRanda -0.27 0 NA
82 hsa-miR-139-5p CAP2 -2.11 0 2.07 0 miRanda -0.2 2.0E-5 NA
83 hsa-miR-193a-3p CAP2 -0.12 0.30939 2.07 0 miRanda -0.24 0.00608 NA
84 hsa-miR-335-3p CAP2 -0.28 0.10663 2.07 0 mirMAP -0.27 0 NA
85 hsa-miR-338-5p CAP2 -0.22 0.25239 2.07 0 PITA -0.14 0.00534 NA
86 hsa-miR-342-3p CAP2 -0.32 0.04498 2.07 0 miRanda -0.29 0 NA
87 hsa-miR-429 CAP2 -1.4 7.0E-5 2.07 0 miRanda -0.19 0 NA
88 hsa-miR-628-5p CAP2 -0.71 0 2.07 0 miRNATAP -0.2 0.00906 NA
89 hsa-miR-139-5p CAPG -2.11 0 1.19 0 miRanda -0.5 0 NA
90 hsa-miR-148a-5p CD44 -0.77 0 -0.09 0.71793 mirMAP -0.31 2.0E-5 23861222 In MHCC97H and MHCC97L cells over-expression of miR-148a blocked the EMT process attenuated the expression of CD90 and CD44 biomarkers for liver cancer stem cells and inhibited their migratory capacity
91 hsa-miR-27b-3p CD44 -0.82 0 -0.09 0.71793 miRNATAP -0.35 0.0007 NA
92 hsa-miR-28-5p CD44 -0.43 0 -0.09 0.71793 miRanda -0.45 0.00041 NA
93 hsa-miR-30c-1-3p CD44 -1.39 0 -0.09 0.71793 MirTarget -0.32 0 NA
94 hsa-miR-30e-3p CD44 -1.21 0 -0.09 0.71793 mirMAP -0.33 0.0004 NA
95 hsa-miR-33a-3p CD44 -0.68 1.0E-5 -0.09 0.71793 mirMAP -0.33 1.0E-5 NA
96 hsa-miR-340-5p CD44 -0 0.9685 -0.09 0.71793 mirMAP -0.4 3.0E-5 NA
97 hsa-miR-616-5p CD44 0.15 0.40284 -0.09 0.71793 mirMAP -0.24 0.00015 NA
98 hsa-miR-362-3p CD59 0.81 0 0.04 0.69266 MirTarget -0.11 0.00171 NA
99 hsa-miR-590-3p CD59 -0.47 2.0E-5 0.04 0.69266 mirMAP -0.18 4.0E-5 NA
100 hsa-miR-92a-3p CD59 0.21 0.13429 0.04 0.69266 miRNAWalker2 validate -0.29 0 NA
101 hsa-miR-144-5p CDH11 -1.55 0 0.64 0.02989 mirMAP -0.19 0.00093 NA
102 hsa-miR-32-3p CDH11 0.22 0.20722 0.64 0.02989 mirMAP -0.43 0 NA
103 hsa-miR-616-5p CDH11 0.15 0.40284 0.64 0.02989 mirMAP -0.33 4.0E-5 NA
104 hsa-miR-144-3p CDH6 -2.98 0 -0.01 0.96649 MirTarget -0.16 0.00042 NA
105 hsa-miR-204-5p CDH6 -0.54 0.03309 -0.01 0.96649 mirMAP -0.26 0 NA
106 hsa-miR-33a-3p CDH6 -0.68 1.0E-5 -0.01 0.96649 mirMAP -0.32 0.00016 NA
107 hsa-miR-374a-5p CDH6 0.02 0.86978 -0.01 0.96649 mirMAP -0.49 0.00022 NA
108 hsa-miR-374b-5p CDH6 -0.31 0.00301 -0.01 0.96649 mirMAP -0.34 0.00676 NA
109 hsa-miR-502-3p CDH6 0.66 0 -0.01 0.96649 MirTarget -0.34 0.00158 NA
110 hsa-miR-576-5p CDH6 -0.38 0.00471 -0.01 0.96649 PITA; mirMAP -0.26 0.00901 NA
111 hsa-miR-616-5p CDH6 0.15 0.40284 -0.01 0.96649 mirMAP -0.34 0 NA
112 hsa-miR-139-5p COL11A1 -2.11 0 1.55 0.00062 miRanda -0.48 1.0E-5 NA
113 hsa-miR-26b-5p COL11A1 -1.11 0 1.55 0.00062 miRNATAP -0.58 0.0016 NA
114 hsa-miR-32-3p COL11A1 0.22 0.20722 1.55 0.00062 miRNATAP -0.41 0.00172 NA
115 hsa-miR-32-5p COL11A1 0.08 0.54898 1.55 0.00062 MirTarget -1 0 NA
116 hsa-miR-374a-3p COL11A1 -0.21 0.06235 1.55 0.00062 MirTarget; miRNATAP -0.65 0.0012 NA
117 hsa-miR-374a-5p COL11A1 0.02 0.86978 1.55 0.00062 mirMAP -0.84 0.00016 NA
118 hsa-miR-374b-5p COL11A1 -0.31 0.00301 1.55 0.00062 mirMAP -0.81 0.00015 NA
119 hsa-miR-455-3p COL11A1 -1.4 0 1.55 0.00062 MirTarget; PITA -0.76 0 NA
120 hsa-miR-107 COL12A1 0.24 0.01708 -0.13 0.57036 miRanda -0.76 0 NA
121 hsa-miR-1180-3p COL12A1 1.14 0 -0.13 0.57036 MirTarget -0.25 3.0E-5 NA
122 hsa-miR-15a-5p COL12A1 0.35 0.00077 -0.13 0.57036 MirTarget; miRNATAP -0.44 6.0E-5 NA
123 hsa-miR-17-3p COL12A1 0.41 0.00422 -0.13 0.57036 MirTarget; miRNATAP -0.36 1.0E-5 NA
124 hsa-miR-30d-3p COL12A1 -0.12 0.32955 -0.13 0.57036 miRNATAP -0.24 0.00996 NA
125 hsa-miR-32-5p COL12A1 0.08 0.54898 -0.13 0.57036 miRNATAP -0.43 0 NA
126 hsa-miR-34a-5p COL12A1 1.04 0 -0.13 0.57036 MirTarget; miRNATAP -0.25 0.00141 NA
127 hsa-miR-502-3p COL12A1 0.66 0 -0.13 0.57036 PITA -0.26 0.00615 NA
128 hsa-miR-532-5p COL12A1 1.03 0 -0.13 0.57036 PITA -0.49 0 NA
129 hsa-miR-590-5p COL12A1 -0.1 0.31003 -0.13 0.57036 PITA; miRanda -0.43 0.00014 NA
130 hsa-miR-92a-3p COL12A1 0.21 0.13429 -0.13 0.57036 miRNATAP -0.33 3.0E-5 NA
131 hsa-miR-107 COL1A1 0.24 0.01708 0.83 0.00649 PITA; miRanda -1.04 0 NA
132 hsa-miR-193a-5p COL1A1 -0.47 1.0E-5 0.83 0.00649 PITA; TargetScan; miRNATAP -0.63 0 NA
133 hsa-miR-20a-5p COL1A1 0.85 0 0.83 0.00649 mirMAP -0.23 0.0068 NA
134 hsa-miR-23b-5p COL1A1 -1.05 0 0.83 0.00649 mirMAP -0.27 0.00678 NA
135 hsa-miR-30b-3p COL1A1 -0.44 0.00095 0.83 0.00649 miRNATAP -0.41 0.00025 NA
136 hsa-miR-30e-3p COL1A1 -1.21 0 0.83 0.00649 mirMAP -0.44 0.00029 NA
137 hsa-miR-532-3p COL1A1 0.3 0.01463 0.83 0.00649 PITA; miRNATAP -0.46 0.00016 NA
138 hsa-miR-616-5p COL1A1 0.15 0.40284 0.83 0.00649 mirMAP; miRNATAP -0.46 0 NA
139 hsa-miR-26b-5p COL1A2 -1.11 0 0.58 0.02674 MirTarget; miRNATAP -0.34 0.00154 NA
140 hsa-miR-30d-3p COL1A2 -0.12 0.32955 0.58 0.02674 MirTarget -0.27 0.00929 NA
141 hsa-miR-30e-3p COL1A2 -1.21 0 0.58 0.02674 MirTarget -0.28 0.00682 NA
142 hsa-miR-32-3p COL1A2 0.22 0.20722 0.58 0.02674 miRNATAP -0.37 0 NA
143 hsa-miR-32-5p COL1A2 0.08 0.54898 0.58 0.02674 MirTarget; miRNATAP -0.61 0 NA
144 hsa-miR-33a-3p COL1A2 -0.68 1.0E-5 0.58 0.02674 MirTarget -0.5 0 NA
145 hsa-miR-7-1-3p COL1A2 -0.57 2.0E-5 0.58 0.02674 mirMAP -0.26 0.00577 NA
146 hsa-miR-92a-3p COL1A2 0.21 0.13429 0.58 0.02674 MirTarget; miRNATAP -0.31 0.00054 NA
147 hsa-miR-107 COL3A1 0.24 0.01708 -0.47 0.08777 miRanda -1.02 0 NA
148 hsa-miR-128-3p COL3A1 0.29 0.01144 -0.47 0.08777 MirTarget -0.44 0.00022 NA
149 hsa-miR-186-5p COL3A1 -0.06 0.53529 -0.47 0.08777 miRNATAP -0.51 0.0003 NA
150 hsa-miR-28-5p COL3A1 -0.43 0 -0.47 0.08777 miRanda -0.5 0.00079 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR STRUCTURE ORGANIZATION 59 304 1.481e-66 6.89e-63
2 TISSUE DEVELOPMENT 73 1518 2.762e-39 6.426e-36
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 50 788 2.153e-31 2.505e-28
4 CIRCULATORY SYSTEM DEVELOPMENT 50 788 2.153e-31 2.505e-28
5 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 50 957 1.83e-27 1.42e-24
6 VASCULATURE DEVELOPMENT 38 469 1.75e-27 1.42e-24
7 ORGAN MORPHOGENESIS 47 841 5.372e-27 3.571e-24
8 REGULATION OF CELLULAR COMPONENT MOVEMENT 45 771 1.381e-26 8.033e-24
9 BIOLOGICAL ADHESION 49 1032 4.969e-25 2.569e-22
10 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 60 1672 1.219e-24 5.672e-22
11 BLOOD VESSEL MORPHOGENESIS 32 364 3.055e-24 1.292e-21
12 REGULATION OF CELL ADHESION 39 629 6.565e-24 2.545e-21
13 RESPONSE TO WOUNDING 37 563 1.511e-23 5.409e-21
14 COLLAGEN FIBRIL ORGANIZATION 15 38 2.377e-22 7.898e-20
15 TISSUE MORPHOGENESIS 35 533 2.925e-22 9.072e-20
16 CELL DEVELOPMENT 53 1426 3.298e-22 9.592e-20
17 ANGIOGENESIS 27 293 4.618e-21 1.264e-18
18 LOCOMOTION 46 1114 6.066e-21 1.568e-18
19 WOUND HEALING 32 470 7.689e-21 1.883e-18
20 REGULATION OF CELL DIFFERENTIATION 52 1492 1.646e-20 3.829e-18
21 EXTRACELLULAR MATRIX DISASSEMBLY 17 76 2.406e-20 5.332e-18
22 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 48 1275 3.228e-20 6.828e-18
23 POSITIVE REGULATION OF LOCOMOTION 30 420 3.761e-20 7.608e-18
24 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 17 79 4.93e-20 9.559e-18
25 CELL MOTILITY 39 835 1.582e-19 2.831e-17
26 LOCALIZATION OF CELL 39 835 1.582e-19 2.831e-17
27 EPITHELIUM DEVELOPMENT 41 945 2.233e-19 3.847e-17
28 POSITIVE REGULATION OF CELL ADHESION 28 376 2.531e-19 4.207e-17
29 SKELETAL SYSTEM DEVELOPMENT 30 455 3.603e-19 5.781e-17
30 REGULATION OF CELL PROLIFERATION 50 1496 6.714e-19 1.041e-16
31 MULTICELLULAR ORGANISM METABOLIC PROCESS 17 93 9.675e-19 1.452e-16
32 RESPONSE TO ENDOGENOUS STIMULUS 49 1450 1.068e-18 1.554e-16
33 RESPONSE TO GROWTH FACTOR 30 475 1.201e-18 1.693e-16
34 REGULATION OF CELL SUBSTRATE ADHESION 20 173 9.135e-18 1.25e-15
35 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 229 1.074e-17 1.427e-15
36 ENDODERM DEVELOPMENT 15 71 1.122e-17 1.45e-15
37 FORMATION OF PRIMARY GERM LAYER 17 110 1.929e-17 2.426e-15
38 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 42 1142 3.039e-17 3.721e-15
39 EMBRYONIC MORPHOGENESIS 30 539 3.947e-17 4.71e-15
40 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 39 983 4.231e-17 4.921e-15
41 ENDODERM FORMATION 13 50 9.211e-17 1.02e-14
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 45 1360 9.199e-17 1.02e-14
43 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 35 801 1.246e-16 1.348e-14
44 ENDODERMAL CELL DIFFERENTIATION 12 40 2.083e-16 2.203e-14
45 POSITIVE REGULATION OF RESPONSE TO STIMULUS 53 1929 2.167e-16 2.241e-14
46 GASTRULATION 18 155 3.97e-16 4.015e-14
47 EMBRYO DEVELOPMENT 36 894 5.462e-16 5.408e-14
48 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 513 8.238e-16 7.823e-14
49 NEGATIVE REGULATION OF CELL COMMUNICATION 41 1192 8.073e-16 7.823e-14
50 OSSIFICATION 21 251 1.038e-15 9.664e-14
51 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 37 1008 3.722e-15 3.396e-13
52 RESPONSE TO OXYGEN CONTAINING COMPOUND 43 1381 4.627e-15 4.141e-13
53 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 37 1021 5.558e-15 4.88e-13
54 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 43 1395 6.598e-15 5.685e-13
55 CELL JUNCTION ORGANIZATION 18 185 9.295e-15 7.863e-13
56 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 49 1848 1.765e-14 1.467e-12
57 CONNECTIVE TISSUE DEVELOPMENT 18 194 2.142e-14 1.749e-12
58 NEGATIVE REGULATION OF LOCOMOTION 20 263 3.234e-14 2.594e-12
59 NEUROGENESIS 42 1402 3.925e-14 3.096e-12
60 POSITIVE REGULATION OF CHEMOTAXIS 15 120 4.149e-14 3.218e-12
61 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 14 99 5.225e-14 3.985e-12
62 POSITIVE REGULATION OF CELL PROLIFERATION 32 814 5.8e-14 4.353e-12
63 POSITIVE REGULATION OF CELL DIFFERENTIATION 32 823 7.835e-14 5.787e-12
64 RESPONSE TO LIPID 33 888 1.065e-13 7.74e-12
65 RESPONSE TO HORMONE 33 893 1.245e-13 8.912e-12
66 CELLULAR COMPONENT MORPHOGENESIS 33 900 1.547e-13 1.091e-11
67 POSITIVE REGULATION OF CELL COMMUNICATION 43 1532 1.695e-13 1.177e-11
68 REGULATION OF CELL DEATH 42 1472 2.031e-13 1.39e-11
69 NEGATIVE REGULATION OF CELL PROLIFERATION 28 643 2.29e-13 1.544e-11
70 REGULATION OF PHOSPHORUS METABOLIC PROCESS 44 1618 2.449e-13 1.628e-11
71 CELL SUBSTRATE ADHESION 16 164 2.922e-13 1.915e-11
72 TUBE DEVELOPMENT 26 552 3.045e-13 1.968e-11
73 NEGATIVE REGULATION OF CELL DIFFERENTIATION 27 609 4.241e-13 2.703e-11
74 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 15 144 6.351e-13 3.993e-11
75 CELL MATRIX ADHESION 14 119 7.089e-13 4.398e-11
76 REGULATION OF CELL GROWTH 22 391 7.285e-13 4.426e-11
77 CELL SUBSTRATE JUNCTION ASSEMBLY 10 41 7.324e-13 4.426e-11
78 RESPONSE TO EXTERNAL STIMULUS 46 1821 8.293e-13 4.947e-11
79 CARTILAGE DEVELOPMENT 15 147 8.613e-13 5.057e-11
80 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 17 207 8.694e-13 5.057e-11
81 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 14 121 8.951e-13 5.142e-11
82 RESPONSE TO MECHANICAL STIMULUS 17 210 1.099e-12 6.234e-11
83 MORPHOGENESIS OF AN EPITHELIUM 22 400 1.147e-12 6.43e-11
84 REGULATION OF CHEMOTAXIS 16 180 1.245e-12 6.897e-11
85 HEART DEVELOPMENT 23 466 3.142e-12 1.72e-10
86 RESPONSE TO ABIOTIC STIMULUS 33 1024 5.297e-12 2.866e-10
87 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 34 1087 5.409e-12 2.893e-10
88 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 33 1036 7.244e-12 3.787e-10
89 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 33 1036 7.244e-12 3.787e-10
90 RESPONSE TO ACID CHEMICAL 19 319 1.118e-11 5.781e-10
91 NEGATIVE REGULATION OF CELL DEATH 30 872 1.154e-11 5.901e-10
92 NEURON DIFFERENTIATION 30 874 1.222e-11 6.179e-10
93 REGULATION OF EPITHELIAL CELL PROLIFERATION 18 285 1.528e-11 7.647e-10
94 REGULATION OF CELL DEVELOPMENT 29 836 2.198e-11 1.088e-09
95 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 34 1152 2.64e-11 1.293e-09
96 CELL JUNCTION ASSEMBLY 13 129 3.555e-11 1.723e-09
97 REGULATION OF PEPTIDASE ACTIVITY 20 392 5.074e-11 2.434e-09
98 INTEGRIN MEDIATED SIGNALING PATHWAY 11 82 5.216e-11 2.477e-09
99 PLATELET DEGRANULATION 12 107 5.836e-11 2.743e-09
100 REGULATION OF MAPK CASCADE 25 660 1.007e-10 4.684e-09
101 REGULATION OF PROTEIN MODIFICATION PROCESS 41 1710 1.056e-10 4.863e-09
102 AMINOGLYCAN CATABOLIC PROCESS 10 68 1.579e-10 7.203e-09
103 NEURON DEVELOPMENT 25 687 2.332e-10 1.054e-08
104 REGULATION OF GROWTH 24 633 2.437e-10 1.09e-08
105 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 17 296 2.546e-10 1.128e-08
106 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 26 750 2.776e-10 1.218e-08
107 UROGENITAL SYSTEM DEVELOPMENT 17 299 2.976e-10 1.294e-08
108 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 13 154 3.325e-10 1.433e-08
109 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 14 190 4.134e-10 1.765e-08
110 SENSORY ORGAN DEVELOPMENT 21 493 4.475e-10 1.893e-08
111 RESPONSE TO STEROID HORMONE 21 497 5.179e-10 2.171e-08
112 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 39 1656 5.751e-10 2.383e-08
113 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 11 102 5.786e-10 2.383e-08
114 REGULATION OF VASCULATURE DEVELOPMENT 15 233 6.325e-10 2.582e-08
115 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 11 103 6.434e-10 2.603e-08
116 RESPONSE TO ALCOHOL 18 362 7.543e-10 3.026e-08
117 GROWTH 19 410 8.024e-10 3.191e-08
118 SINGLE ORGANISM CELL ADHESION 20 459 8.134e-10 3.208e-08
119 REGULATION OF EPITHELIAL CELL MIGRATION 13 166 8.442e-10 3.301e-08
120 RESPONSE TO ORGANIC CYCLIC COMPOUND 28 917 9.324e-10 3.615e-08
121 TAXIS 20 464 9.811e-10 3.773e-08
122 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 28 926 1.159e-09 4.422e-08
123 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 24 689 1.328e-09 5.022e-08
124 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 31 1135 1.53e-09 5.74e-08
125 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 36 1492 1.634e-09 6.084e-08
126 MUSCLE STRUCTURE DEVELOPMENT 19 432 1.906e-09 7.04e-08
127 REGULATION OF CELLULAR COMPONENT BIOGENESIS 25 767 2.247e-09 8.232e-08
128 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 9 67 3.079e-09 1.119e-07
129 REGULATION OF CELL MORPHOGENESIS 21 552 3.377e-09 1.218e-07
130 REGULATION OF NEURON DIFFERENTIATION 21 554 3.6e-09 1.288e-07
131 CELL PROLIFERATION 23 672 4.236e-09 1.505e-07
132 RESPONSE TO OXYGEN LEVELS 16 311 4.303e-09 1.517e-07
133 REGULATION OF LEUKOCYTE CHEMOTAXIS 10 96 5.059e-09 1.77e-07
134 OSTEOBLAST DIFFERENTIATION 11 126 5.598e-09 1.944e-07
135 CELLULAR COMPONENT DISASSEMBLY 20 515 5.823e-09 2.007e-07
136 RESPONSE TO VITAMIN 10 98 6.196e-09 2.104e-07
137 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 98 6.196e-09 2.104e-07
138 TUBE MORPHOGENESIS 16 323 7.372e-09 2.486e-07
139 NEGATIVE REGULATION OF MOLECULAR FUNCTION 29 1079 8.079e-09 2.704e-07
140 NEGATIVE REGULATION OF PROTEOLYSIS 16 329 9.565e-09 3.156e-07
141 AMINOGLYCAN METABOLIC PROCESS 12 166 9.556e-09 3.156e-07
142 MORPHOGENESIS OF A BRANCHING STRUCTURE 12 167 1.023e-08 3.351e-07
143 SINGLE ORGANISM CATABOLIC PROCESS 27 957 1.043e-08 3.393e-07
144 REGULATION OF BMP SIGNALING PATHWAY 9 77 1.085e-08 3.507e-07
145 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 14 245 1.114e-08 3.576e-07
146 REGULATION OF PROTEOLYSIS 23 711 1.217e-08 3.879e-07
147 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 337 1.342e-08 4.247e-07
148 REGULATION OF HYDROLASE ACTIVITY 32 1327 1.616e-08 5.081e-07
149 HEART MORPHOGENESIS 13 212 1.647e-08 5.143e-07
150 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 9 81 1.708e-08 5.298e-07
151 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 10 109 1.749e-08 5.391e-07
152 GLAND DEVELOPMENT 17 395 1.968e-08 6.024e-07
153 REGULATION OF OSSIFICATION 12 178 2.091e-08 6.36e-07
154 REGULATION OF BODY FLUID LEVELS 19 506 2.465e-08 7.447e-07
155 REGULATION OF ENDOTHELIAL CELL MIGRATION 10 114 2.699e-08 8.102e-07
156 AGING 14 264 2.862e-08 8.535e-07
157 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 25 876 3.149e-08 9.299e-07
158 REGULATION OF NEURON PROJECTION DEVELOPMENT 17 408 3.158e-08 9.299e-07
159 REGULATION OF LEUKOCYTE MIGRATION 11 149 3.246e-08 9.5e-07
160 REGULATION OF CARTILAGE DEVELOPMENT 8 63 3.753e-08 1.091e-06
161 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 7 42 3.92e-08 1.132e-06
162 EPITHELIAL CELL PROLIFERATION 9 89 3.94e-08 1.132e-06
163 RESPONSE TO REACTIVE OXYGEN SPECIES 12 191 4.576e-08 1.306e-06
164 REGULATION OF RESPONSE TO STRESS 33 1468 4.985e-08 1.414e-06
165 NEGATIVE REGULATION OF PHOSPHORYLATION 17 422 5.149e-08 1.452e-06
166 CELL PROJECTION ORGANIZATION 25 902 5.548e-08 1.555e-06
167 RESPONSE TO INORGANIC SUBSTANCE 18 479 5.836e-08 1.626e-06
168 EYE DEVELOPMENT 15 326 5.888e-08 1.631e-06
169 REGULATION OF IMMUNE SYSTEM PROCESS 32 1403 5.94e-08 1.636e-06
170 REGULATION OF CELL JUNCTION ASSEMBLY 8 68 6.925e-08 1.895e-06
171 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 95 6.993e-08 1.903e-06
172 REGENERATION 11 161 7.215e-08 1.952e-06
173 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 11 162 7.688e-08 2.068e-06
174 NEURON PROJECTION DEVELOPMENT 19 545 7.938e-08 2.123e-06
175 POSITIVE REGULATION OF CELL DEATH 20 605 8.368e-08 2.225e-06
176 REGULATION OF CELL PROJECTION ORGANIZATION 19 558 1.145e-07 3.028e-06
177 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 21 684 1.341e-07 3.526e-06
178 CELL GROWTH 10 135 1.353e-07 3.537e-06
179 ARTERY DEVELOPMENT 8 75 1.507e-07 3.884e-06
180 CELL ACTIVATION 19 568 1.507e-07 3.884e-06
181 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 12 213 1.511e-07 3.884e-06
182 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 9 104 1.538e-07 3.932e-06
183 NEGATIVE REGULATION OF CELL DEVELOPMENT 14 303 1.578e-07 4.011e-06
184 CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 11 174 1.593e-07 4.027e-06
185 CELLULAR RESPONSE TO ACID CHEMICAL 11 175 1.688e-07 4.245e-06
186 RESPONSE TO CORTICOSTEROID 11 176 1.788e-07 4.473e-06
187 REPRODUCTIVE SYSTEM DEVELOPMENT 16 408 1.873e-07 4.661e-06
188 CARDIAC MUSCLE TISSUE DEVELOPMENT 10 140 1.905e-07 4.714e-06
189 RESPONSE TO ESTROGEN 12 218 1.943e-07 4.783e-06
190 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 262 1.972e-07 4.828e-06
191 CELLULAR RESPONSE TO AMINO ACID STIMULUS 7 53 2.081e-07 5.069e-06
192 RESPONSE TO VITAMIN D 6 33 2.21e-07 5.357e-06
193 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 10 144 2.479e-07 5.953e-06
194 NEGATIVE REGULATION OF CELL ADHESION 12 223 2.482e-07 5.953e-06
195 SECRETION 19 588 2.565e-07 6.12e-06
196 REGULATED EXOCYTOSIS 12 224 2.605e-07 6.183e-06
197 RESPONSE TO AMINO ACID 9 112 2.913e-07 6.845e-06
198 REGULATION OF OSTEOBLAST DIFFERENTIATION 9 112 2.913e-07 6.845e-06
199 EPITHELIAL TO MESENCHYMAL TRANSITION 7 56 3.068e-07 7.174e-06
200 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 13 274 3.294e-07 7.663e-06
201 POSITIVE REGULATION OF ENDOCYTOSIS 9 114 3.39e-07 7.847e-06
202 MUSCLE TISSUE DEVELOPMENT 13 275 3.434e-07 7.909e-06
203 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 9 115 3.653e-07 8.372e-06
204 MUSCLE ORGAN DEVELOPMENT 13 277 3.729e-07 8.506e-06
205 POSITIVE CHEMOTAXIS 6 36 3.811e-07 8.65e-06
206 PROTEIN COMPLEX SUBUNIT ORGANIZATION 32 1527 4.047e-07 9.14e-06
207 RESPONSE TO NUTRIENT 11 191 4.07e-07 9.148e-06
208 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 22 799 4.248e-07 9.496e-06
209 CELL CELL ADHESION 19 608 4.265e-07 9.496e-06
210 POSITIVE REGULATION OF TRANSPORT 24 936 4.366e-07 9.674e-06
211 CENTRAL NERVOUS SYSTEM DEVELOPMENT 23 872 4.788e-07 1.056e-05
212 DEVELOPMENTAL GROWTH 14 333 4.951e-07 1.087e-05
213 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 60 4.974e-07 1.087e-05
214 SYSTEM PROCESS 35 1785 5.021e-07 1.092e-05
215 SENSORY ORGAN MORPHOGENESIS 12 239 5.214e-07 1.128e-05
216 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 11 197 5.539e-07 1.193e-05
217 REGULATION OF ENDOCYTOSIS 11 199 6.124e-07 1.313e-05
218 REGULATION OF CELL MATRIX ADHESION 8 90 6.258e-07 1.33e-05
219 REGULATION OF TISSUE REMODELING 7 62 6.25e-07 1.33e-05
220 REGULATION OF TRANSPORT 35 1804 6.44e-07 1.362e-05
221 SKELETAL SYSTEM MORPHOGENESIS 11 201 6.762e-07 1.424e-05
222 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 10 162 7.383e-07 1.547e-05
223 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 22 829 7.879e-07 1.644e-05
224 AORTA DEVELOPMENT 6 41 8.512e-07 1.768e-05
225 REGULATION OF OSTEOBLAST PROLIFERATION 5 23 9.218e-07 1.898e-05
226 TRABECULA FORMATION 5 23 9.218e-07 1.898e-05
227 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 15 406 9.761e-07 2.001e-05
228 HEAD DEVELOPMENT 20 709 1.03e-06 2.102e-05
229 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 9 131 1.101e-06 2.238e-05
230 NEGATIVE REGULATION OF CELL GROWTH 10 170 1.147e-06 2.321e-05
231 REGULATION OF POSITIVE CHEMOTAXIS 5 24 1.157e-06 2.33e-05
232 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 7 68 1.184e-06 2.374e-05
233 MULTI MULTICELLULAR ORGANISM PROCESS 11 213 1.198e-06 2.392e-05
234 POSITIVE REGULATION OF MAPK CASCADE 16 470 1.225e-06 2.436e-05
235 BONE TRABECULA MORPHOGENESIS 4 11 1.246e-06 2.466e-05
236 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 9 133 1.251e-06 2.466e-05
237 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 99 1.301e-06 2.543e-05
238 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 8 99 1.301e-06 2.543e-05
239 HEMOSTASIS 13 311 1.373e-06 2.673e-05
240 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 100 1.404e-06 2.711e-05
241 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 100 1.404e-06 2.711e-05
242 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 1.437e-06 2.763e-05
243 SPROUTING ANGIOGENESIS 6 45 1.502e-06 2.875e-05
244 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 22 867 1.651e-06 3.136e-05
245 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 18 602 1.646e-06 3.136e-05
246 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 17 541 1.672e-06 3.15e-05
247 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 17 541 1.672e-06 3.15e-05
248 CELLULAR RESPONSE TO VITAMIN 5 26 1.767e-06 3.316e-05
249 HEMIDESMOSOME ASSEMBLY 4 12 1.858e-06 3.471e-05
250 SECRETION BY CELL 16 486 1.891e-06 3.52e-05
251 RESPONSE TO DRUG 15 431 2.046e-06 3.792e-05
252 RESPONSE TO KETONE 10 182 2.129e-06 3.932e-05
253 AXIS ELONGATION 5 27 2.155e-06 3.964e-05
254 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 17 554 2.304e-06 4.22e-05
255 AMINOGLYCAN BIOSYNTHETIC PROCESS 8 107 2.346e-06 4.281e-05
256 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 6 49 2.511e-06 4.556e-05
257 MUCOPOLYSACCHARIDE METABOLIC PROCESS 8 108 2.517e-06 4.556e-05
258 INDUCTION OF POSITIVE CHEMOTAXIS 4 13 2.666e-06 4.809e-05
259 RESPONSE TO HYDROGEN PEROXIDE 8 109 2.698e-06 4.846e-05
260 RESPONSE TO ESTRADIOL 9 146 2.718e-06 4.864e-05
261 REGULATION OF ADHERENS JUNCTION ORGANIZATION 6 50 2.835e-06 5.034e-05
262 FACE DEVELOPMENT 6 50 2.835e-06 5.034e-05
263 RESPONSE TO METAL ION 13 333 2.92e-06 5.166e-05
264 ARTERY MORPHOGENESIS 6 51 3.192e-06 5.625e-05
265 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 236 3.244e-06 5.697e-05
266 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 10 191 3.284e-06 5.745e-05
267 CELLULAR RESPONSE TO VITAMIN D 4 14 3.71e-06 6.465e-05
268 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 14 397 3.911e-06 6.79e-05
269 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 4.015e-06 6.875e-05
270 ORGANONITROGEN COMPOUND CATABOLIC PROCESS 13 343 4.033e-06 6.875e-05
271 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 6 53 4.015e-06 6.875e-05
272 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 9 153 3.997e-06 6.875e-05
273 CELLULAR RESPONSE TO ALCOHOL 8 115 4.033e-06 6.875e-05
274 REGULATION OF ORGAN MORPHOGENESIS 11 242 4.129e-06 7.011e-05
275 MAMMARY GLAND DEVELOPMENT 8 117 4.588e-06 7.763e-05
276 REGULATION OF VESICLE MEDIATED TRANSPORT 15 462 4.766e-06 8.034e-05
277 MESODERM DEVELOPMENT 8 118 4.888e-06 8.211e-05
278 POSITIVE REGULATION OF OSSIFICATION 7 84 4.969e-06 8.316e-05
279 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 4 15 5.027e-06 8.384e-05
280 RESPONSE TO NITROGEN COMPOUND 21 859 5.186e-06 8.618e-05
281 RESPONSE TO OXIDATIVE STRESS 13 352 5.341e-06 8.844e-05
282 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 7 87 6.283e-06 0.0001001
283 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 7 87 6.283e-06 0.0001001
284 ENDOTHELIAL CELL MIGRATION 6 57 6.181e-06 0.0001001
285 VIRAL ENTRY INTO HOST CELL 7 87 6.283e-06 0.0001001
286 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 7 87 6.283e-06 0.0001001
287 REGULATION OF RESPONSE TO WOUNDING 14 413 6.148e-06 0.0001001
288 NEURON PROJECTION REGENERATION 5 33 6.095e-06 0.0001001
289 MOVEMENT IN HOST ENVIRONMENT 7 87 6.283e-06 0.0001001
290 ENTRY INTO HOST 7 87 6.283e-06 0.0001001
291 POSITIVE REGULATION OF CELL DEVELOPMENT 15 472 6.165e-06 0.0001001
292 ENTRY INTO HOST CELL 7 87 6.283e-06 0.0001001
293 EXTRACELLULAR MATRIX ASSEMBLY 4 16 6.661e-06 0.0001054
294 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 4 16 6.661e-06 0.0001054
295 REGULATION OF STEM CELL PROLIFERATION 7 88 6.78e-06 0.0001069
296 REGULATION OF APOPTOTIC SIGNALING PATHWAY 13 363 7.44e-06 0.0001169
297 KIDNEY EPITHELIUM DEVELOPMENT 8 125 7.497e-06 0.0001175
298 REGULATION OF WNT SIGNALING PATHWAY 12 310 7.754e-06 0.0001207
299 EXOCYTOSIS 12 310 7.754e-06 0.0001207
300 LEUKOCYTE MIGRATION 11 259 7.876e-06 0.0001217
301 MESONEPHROS DEVELOPMENT 7 90 7.874e-06 0.0001217
302 SKIN DEVELOPMENT 10 211 7.938e-06 0.0001223
303 NEGATIVE REGULATION OF PROTEIN PROCESSING 5 35 8.23e-06 0.000126
304 NEGATIVE REGULATION OF PROTEIN MATURATION 5 35 8.23e-06 0.000126
305 REGULATION OF AXONOGENESIS 9 168 8.56e-06 0.0001306
306 BRANCH ELONGATION OF AN EPITHELIUM 4 17 8.657e-06 0.0001308
307 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 4 17 8.657e-06 0.0001308
308 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 13 368 8.613e-06 0.0001308
309 CELLULAR RESPONSE TO HORMONE STIMULUS 16 552 9.504e-06 0.0001427
310 HEAD MORPHOGENESIS 5 36 9.496e-06 0.0001427
311 POSITIVE REGULATION OF CATALYTIC ACTIVITY 29 1518 9.546e-06 0.0001428
312 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 13 372 9.667e-06 0.0001442
313 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 10 216 9.746e-06 0.0001449
314 EPITHELIAL CELL DIFFERENTIATION 15 495 1.086e-05 0.0001609
315 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 12 321 1.101e-05 0.0001626
316 REGULATION OF LYMPHOCYTE DIFFERENTIATION 8 132 1.12e-05 0.0001649
317 GLIOGENESIS 9 175 1.189e-05 0.0001746
318 POSITIVE REGULATION OF MOLECULAR FUNCTION 32 1791 1.202e-05 0.0001759
319 INTERACTION WITH HOST 8 134 1.25e-05 0.0001812
320 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 5 38 1.248e-05 0.0001812
321 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 5 38 1.248e-05 0.0001812
322 GLAND MORPHOGENESIS 7 97 1.292e-05 0.0001858
323 RESPONSE TO EXTRACELLULAR STIMULUS 14 441 1.289e-05 0.0001858
324 REPRODUCTION 26 1297 1.293e-05 0.0001858
325 EYE MORPHOGENESIS 8 136 1.393e-05 0.0001994
326 SULFUR COMPOUND CATABOLIC PROCESS 5 39 1.422e-05 0.0002018
327 TRABECULA MORPHOGENESIS 5 39 1.422e-05 0.0002018
328 CELLULAR RESPONSE TO NUTRIENT 5 39 1.422e-05 0.0002018
329 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 6 66 1.459e-05 0.000205
330 MESODERM MORPHOGENESIS 6 66 1.459e-05 0.000205
331 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 66 1.459e-05 0.000205
332 REGULATION OF KINASE ACTIVITY 19 776 1.481e-05 0.0002076
333 CELL DEATH 22 1001 1.621e-05 0.0002265
334 RESPONSE TO CYTOKINE 18 714 1.715e-05 0.0002389
335 MUSCLE SYSTEM PROCESS 11 282 1.746e-05 0.0002426
336 REGULATION OF BINDING 11 283 1.805e-05 0.0002499
337 REGULATION OF LEUKOCYTE DIFFERENTIATION 10 232 1.812e-05 0.0002502
338 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 1.828e-05 0.0002516
339 MUSCLE CONTRACTION 10 233 1.881e-05 0.0002581
340 CELLULAR RESPONSE TO LIPID 14 457 1.916e-05 0.0002614
341 REGULATION OF MUSCLE ORGAN DEVELOPMENT 7 103 1.914e-05 0.0002614
342 NEGATIVE REGULATION OF TRANSPORT 14 458 1.963e-05 0.0002671
343 CARDIAC CHAMBER MORPHOGENESIS 7 104 2.039e-05 0.0002766
344 MUSCLE ORGAN MORPHOGENESIS 6 70 2.05e-05 0.0002773
345 REGULATION OF BONE REMODELING 5 42 2.061e-05 0.000278
346 NEGATIVE REGULATION OF GROWTH 10 236 2.099e-05 0.0002823
347 ODONTOGENESIS 7 105 2.17e-05 0.000291
348 NEURON PROJECTION MORPHOGENESIS 13 402 2.191e-05 0.000293
349 ADHERENS JUNCTION ORGANIZATION 6 71 2.225e-05 0.0002966
350 REGULATION OF ERK1 AND ERK2 CASCADE 10 238 2.257e-05 3e-04
351 MESENCHYME DEVELOPMENT 9 190 2.29e-05 0.0003035
352 MORPHOGENESIS OF AN EPITHELIAL SHEET 5 43 2.318e-05 0.0003064
353 REGULATION OF B CELL DIFFERENTIATION 4 22 2.579e-05 0.0003372
354 AORTA MORPHOGENESIS 4 22 2.579e-05 0.0003372
355 CATABOLIC PROCESS 31 1773 2.58e-05 0.0003372
356 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 4 22 2.579e-05 0.0003372
357 BODY MORPHOGENESIS 5 44 2.598e-05 0.0003386
358 EAR DEVELOPMENT 9 195 2.81e-05 0.0003653
359 RESPIRATORY SYSTEM DEVELOPMENT 9 197 3.045e-05 0.0003947
360 RESPONSE TO INCREASED OXYGEN LEVELS 4 23 3.103e-05 0.0003988
361 EPIBOLY 4 23 3.103e-05 0.0003988
362 RESPONSE TO HYPEROXIA 4 23 3.103e-05 0.0003988
363 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 200 3.428e-05 0.0004394
364 OVULATION CYCLE 7 113 3.491e-05 0.0004462
365 REGULATION OF CELL ACTIVATION 14 484 3.596e-05 0.0004576
366 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 47 3.599e-05 0.0004576
367 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 16 616 3.624e-05 0.0004595
368 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 4 24 3.7e-05 0.0004678
369 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 6 78 3.81e-05 0.0004805
370 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 48 3.992e-05 0.0005007
371 RESPONSE TO AXON INJURY 5 48 3.992e-05 0.0005007
372 CIRCULATORY SYSTEM PROCESS 12 366 4.007e-05 0.0005012
373 REGULATION OF CELLULAR RESPONSE TO STRESS 17 691 4.045e-05 0.0005046
374 LEUKOCYTE CELL CELL ADHESION 10 255 4.06e-05 0.0005051
375 FEMALE SEX DIFFERENTIATION 7 116 4.131e-05 0.0005126
376 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 6 80 4.4e-05 0.000543
377 CELLULAR RESPONSE TO MECHANICAL STIMULUS 6 80 4.4e-05 0.000543
378 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 118 4.609e-05 0.0005674
379 REGULATION OF FIBROBLAST PROLIFERATION 6 81 4.721e-05 0.0005795
380 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 8 162 4.904e-05 0.0006004
381 REGULATION OF MESONEPHROS DEVELOPMENT 4 26 5.141e-05 0.0006246
382 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 26 5.141e-05 0.0006246
383 MESODERMAL CELL DIFFERENTIATION 4 26 5.141e-05 0.0006246
384 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 437 5.183e-05 0.0006264
385 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 13 437 5.183e-05 0.0006264
386 CELLULAR RESPONSE TO ABIOTIC STIMULUS 10 263 5.265e-05 0.0006346
387 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 51 5.372e-05 0.0006459
388 REGULATION OF MAP KINASE ACTIVITY 11 319 5.387e-05 0.000646
389 REGULATION OF B CELL ACTIVATION 7 121 5.411e-05 0.0006472
390 CELLULAR RESPONSE TO EXTERNAL STIMULUS 10 264 5.435e-05 0.0006484
391 REGULATION OF CELL CELL ADHESION 12 380 5.751e-05 0.0006843
392 TISSUE MIGRATION 6 84 5.797e-05 0.0006863
393 SEX DIFFERENTIATION 10 266 5.789e-05 0.0006863
394 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 15 573 5.876e-05 0.0006939
395 CELLULAR RESPONSE TO IONIZING RADIATION 5 52 5.905e-05 0.0006956
396 APOPTOTIC CELL CLEARANCE 4 27 5.998e-05 0.0007012
397 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 27 5.998e-05 0.0007012
398 HETEROTYPIC CELL CELL ADHESION 4 27 5.998e-05 0.0007012
399 PALATE DEVELOPMENT 6 85 6.196e-05 0.0007226
400 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 5 53 6.478e-05 0.000748
401 MAMMARY GLAND EPITHELIUM DEVELOPMENT 5 53 6.478e-05 0.000748
402 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 53 6.478e-05 0.000748
403 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 53 6.478e-05 0.000748
404 REGULATION OF FIBROBLAST MIGRATION 4 28 6.954e-05 0.0008009
405 REGULATION OF WOUND HEALING 7 126 6.998e-05 0.0008021
406 IMMUNE SYSTEM DEVELOPMENT 15 582 6.998e-05 0.0008021
407 TISSUE REMODELING 6 87 7.061e-05 0.0008073
408 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 6 88 7.528e-05 0.0008585
409 INFLAMMATORY RESPONSE 13 454 7.627e-05 0.0008677
410 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 55 7.753e-05 0.0008756
411 REGULATION OF KIDNEY DEVELOPMENT 5 55 7.753e-05 0.0008756
412 MUSCLE CELL DEVELOPMENT 7 128 7.731e-05 0.0008756
413 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 11 7.909e-05 0.0008825
414 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 11 7.909e-05 0.0008825
415 NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 11 7.909e-05 0.0008825
416 POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 3 11 7.909e-05 0.0008825
417 BASEMENT MEMBRANE ORGANIZATION 3 11 7.909e-05 0.0008825
418 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 4 29 8.016e-05 0.0008923
419 REGULATION OF CELLULAR LOCALIZATION 24 1277 8.047e-05 0.0008937
420 TUBE FORMATION 7 129 8.12e-05 0.0008996
421 SMAD PROTEIN SIGNAL TRANSDUCTION 5 56 8.459e-05 0.0009304
422 PEPTIDE CROSS LINKING 5 56 8.459e-05 0.0009304
423 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 5 56 8.459e-05 0.0009304
424 EMBRYONIC ORGAN MORPHOGENESIS 10 279 8.608e-05 0.0009447
425 IMMUNE SYSTEM PROCESS 32 1984 8.925e-05 0.0009771
426 NEGATIVE REGULATION OF B CELL ACTIVATION 4 30 9.192e-05 0.001002
427 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 4 30 9.192e-05 0.001002
428 POSITIVE REGULATION OF CELL DIVISION 7 132 9.386e-05 0.00102
429 TELENCEPHALON DEVELOPMENT 9 228 9.434e-05 0.001023
430 NEGATIVE REGULATION OF WOUND HEALING 5 58 0.0001002 0.001084
431 REGULATION OF DNA BINDING 6 93 0.0001025 0.001106
432 MESENCHYMAL CELL DIFFERENTIATION 7 134 0.0001031 0.001111
433 HYALURONAN METABOLIC PROCESS 4 31 0.0001049 0.001122
434 CELL ADHESION MEDIATED BY INTEGRIN 3 12 0.0001048 0.001122
435 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 0.0001048 0.001122
436 EMBRYONIC ORGAN DEVELOPMENT 12 406 0.0001077 0.001149
437 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 5 59 0.0001087 0.001153
438 RESPONSE TO BMP 6 94 0.0001087 0.001153
439 CELLULAR RESPONSE TO BMP STIMULUS 6 94 0.0001087 0.001153
440 REGULATION OF DEVELOPMENTAL GROWTH 10 289 0.000115 0.001216
441 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 5 60 0.0001179 0.001241
442 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 60 0.0001179 0.001241
443 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 32 0.0001191 0.001251
444 LEUKOCYTE DIFFERENTIATION 10 292 0.0001252 0.001312
445 MUSCLE CELL DIFFERENTIATION 9 237 0.0001265 0.001323
446 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 98 0.0001369 0.001429
447 POSITIVE REGULATION OF KINASE ACTIVITY 13 482 0.0001384 0.001438
448 VESICLE MEDIATED TRANSPORT 23 1239 0.0001382 0.001438
449 FOREBRAIN DEVELOPMENT 11 357 0.000146 0.001513
450 RHYTHMIC PROCESS 10 298 0.0001477 0.001527
451 PLATELET ACTIVATION 7 142 0.0001481 0.001528
452 STEM CELL DIFFERENTIATION 8 190 0.0001493 0.001537
453 RESPONSE TO PROSTAGLANDIN 4 34 0.0001517 0.001559
454 POSITIVE REGULATION OF CELL CELL ADHESION 9 243 0.0001527 0.001565
455 REGULATION OF SECRETION 16 699 0.0001585 0.001621
456 CARDIAC CHAMBER DEVELOPMENT 7 144 0.0001615 0.001646
457 REGULATION OF EXTENT OF CELL GROWTH 6 101 0.0001617 0.001646
458 EXTRACELLULAR NEGATIVE REGULATION OF SIGNAL TRANSDUCTION 3 14 0.0001714 0.001727
459 BONE REMODELING 4 35 0.0001702 0.001727
460 EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION 3 14 0.0001714 0.001727
461 POSITIVE REGULATION OF P38MAPK CASCADE 3 14 0.0001714 0.001727
462 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 3 14 0.0001714 0.001727
463 REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 103 0.00018 0.001809
464 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 4 36 0.0001903 0.001909
465 POSITIVE REGULATION OF SECRETION 11 370 0.0001991 0.00199
466 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 5 67 0.0001993 0.00199
467 EPIDERMIS DEVELOPMENT 9 253 0.0002065 0.002057
468 REGULATION OF TRANSFERASE ACTIVITY 19 946 0.0002069 0.002057
469 REGULATION OF FAT CELL DIFFERENTIATION 6 106 0.0002106 0.002082
470 REGULATION OF RECEPTOR INTERNALIZATION 4 37 0.0002121 0.002082
471 CARDIAC VENTRICLE DEVELOPMENT 6 106 0.0002106 0.002082
472 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 37 0.0002121 0.002082
473 GLIAL CELL MIGRATION 4 37 0.0002121 0.002082
474 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 4 37 0.0002121 0.002082
475 HYALURONAN CATABOLIC PROCESS 3 15 0.000213 0.002087
476 REGULATION OF ACTIN FILAMENT BASED PROCESS 10 312 0.000214 0.002092
477 RESPONSE TO RETINOIC ACID 6 107 0.0002216 0.002162
478 REGULATION OF HEMOPOIESIS 10 314 0.0002253 0.002189
479 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 7 152 0.0002254 0.002189
480 NEGATIVE REGULATION OF OSSIFICATION 5 69 0.0002289 0.002219
481 CELL CYCLE ARREST 7 154 0.0002442 0.002357
482 AMEBOIDAL TYPE CELL MIGRATION 7 154 0.0002442 0.002357
483 NEURON PROJECTION GUIDANCE 8 205 0.0002507 0.002415
484 POSITIVE REGULATION OF GENE EXPRESSION 28 1733 0.0002582 0.002482
485 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 39 0.0002609 0.002482
486 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 0.0002607 0.002482
487 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 16 0.0002607 0.002482
488 NEGATIVE CHEMOTAXIS 4 39 0.0002609 0.002482
489 EMBRYO IMPLANTATION 4 39 0.0002609 0.002482
490 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 7 156 0.0002642 0.002504
491 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 7 156 0.0002642 0.002504
492 ACTIN FILAMENT BASED PROCESS 12 450 0.0002784 0.002633
493 LYMPHOCYTE DIFFERENTIATION 8 209 0.0002856 0.002696
494 POSITIVE REGULATION OF CELL MATRIX ADHESION 4 40 0.0002881 0.002713
495 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 5 73 0.0002982 0.002803
496 NEGATIVE REGULATION OF ANOIKIS 3 17 0.0003147 0.002917
497 NEGATIVE REGULATION OF LIPID STORAGE 3 17 0.0003147 0.002917
498 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.0003147 0.002917
499 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.0003147 0.002917
500 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 0.0003124 0.002917
501 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 3 17 0.0003147 0.002917
502 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 3 17 0.0003147 0.002917
503 REGULATION OF LIPID STORAGE 4 41 0.0003172 0.002935
504 RESPONSE TO CALCIUM ION 6 115 0.0003274 0.003023
505 CELL CHEMOTAXIS 7 162 0.0003324 0.003056
506 POSITIVE REGULATION OF RESPONSE TO WOUNDING 7 162 0.0003324 0.003056
507 RESPONSE TO FIBROBLAST GROWTH FACTOR 6 116 0.000343 0.003148
508 POSITIVE REGULATION OF HEMOPOIESIS 7 163 0.000345 0.003153
509 POSITIVE REGULATION OF HYDROLASE ACTIVITY 18 905 0.0003446 0.003153
510 RESPONSE TO CARBOHYDRATE 7 168 0.0004139 0.003776
511 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 44 0.0004174 0.003801
512 REGULATION OF ANATOMICAL STRUCTURE SIZE 12 472 0.0004277 0.003883
513 REGULATION OF SYNAPSE ASSEMBLY 5 79 0.0004306 0.003883
514 APPENDAGE DEVELOPMENT 7 169 0.000429 0.003883
515 LIMB DEVELOPMENT 7 169 0.000429 0.003883
516 BONE MORPHOGENESIS 5 79 0.0004306 0.003883
517 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 19 0.0004431 0.003981
518 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 3 19 0.0004431 0.003981
519 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 4 45 0.0004553 0.004082
520 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 7 171 0.0004603 0.004119
521 METANEPHROS DEVELOPMENT 5 81 0.0004832 0.004316
522 STRIATED MUSCLE CELL DIFFERENTIATION 7 173 0.0004935 0.004399
523 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 0.0004956 0.0044
524 CELL FATE COMMITMENT 8 227 0.0004956 0.0044
525 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 28 1805 0.0004982 0.004416
526 RESPONSE TO RADIATION 11 413 0.0005056 0.004473
527 REGULATION OF PROTEIN MATURATION 5 82 0.0005113 0.004515
528 NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 3 20 0.0005183 0.004533
529 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 0.0005183 0.004533
530 NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 3 20 0.0005183 0.004533
531 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 3 20 0.0005183 0.004533
532 REGULATION OF MONOCYTE CHEMOTAXIS 3 20 0.0005183 0.004533
533 HOMEOSTASIS OF NUMBER OF CELLS 7 175 0.0005285 0.004614
534 WNT SIGNALING PATHWAY 10 351 0.0005421 0.004723
535 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 289 0.0005458 0.004747
536 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 8 232 0.000572 0.004966
537 CELL PART MORPHOGENESIS 14 633 0.0005791 0.005018
538 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 4 48 0.0005836 0.005038
539 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 48 0.0005836 0.005038
540 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 0.0006011 0.00517
541 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 21 0.0006011 0.00517
542 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 5 85 0.000603 0.005176
543 REGULATION OF REPRODUCTIVE PROCESS 6 129 0.000604 0.005176
544 CARDIAC SEPTUM MORPHOGENESIS 4 49 0.0006316 0.005402
545 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 5 86 0.0006362 0.005431
546 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 6 131 0.000655 0.005582
547 POSITIVE REGULATION OF GROWTH 8 238 0.0006761 0.005751
548 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 3 22 0.000692 0.005865
549 REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 22 0.000692 0.005865
550 MYELOID CELL HOMEOSTASIS 5 88 0.0007065 0.005966
551 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 0.0007065 0.005966
552 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 6 134 0.0007377 0.006218
553 EPITHELIAL CELL DEVELOPMENT 7 186 0.0007584 0.006381
554 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 9 303 0.0007646 0.006422
555 MIDBRAIN DEVELOPMENT 5 90 0.0007825 0.00656
556 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 4 52 0.0007921 0.006605
557 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 23 0.0007911 0.006605
558 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 3 23 0.0007911 0.006605
559 NEGATIVE REGULATION OF GENE EXPRESSION 24 1493 0.000805 0.006701
560 POSITIVE REGULATION OF NEURON DIFFERENTIATION 9 306 0.0008198 0.006811
561 FOCAL ADHESION ASSEMBLY 3 24 0.0008989 0.007295
562 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.0008989 0.007295
563 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 3 24 0.0008989 0.007295
564 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 24 0.0008989 0.007295
565 AXON REGENERATION 3 24 0.0008989 0.007295
566 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 0.0008989 0.007295
567 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 3 24 0.0008989 0.007295
568 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 24 0.0008989 0.007295
569 REGULATION OF PROTEIN COMPLEX ASSEMBLY 10 375 0.0008999 0.007295
570 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 3 24 0.0008989 0.007295
571 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 3 24 0.0008989 0.007295
572 REGULATION OF ANOIKIS 3 24 0.0008989 0.007295
573 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 3 24 0.0008989 0.007295
574 REGULATION OF CELL SHAPE 6 139 0.0008932 0.007295
575 ACTIN FILAMENT BASED MOVEMENT 5 93 0.0009078 0.007346
576 CARDIAC MUSCLE TISSUE MORPHOGENESIS 4 54 0.0009139 0.007383
577 POSITIVE REGULATION OF CELL ACTIVATION 9 311 0.0009188 0.00741
578 NEGATIVE REGULATION OF KINASE ACTIVITY 8 250 0.0009301 0.007488
579 CANONICAL WNT SIGNALING PATHWAY 5 95 0.0009992 0.00803
580 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 3 25 0.001015 0.008105
581 RESPONSE TO PROSTAGLANDIN E 3 25 0.001015 0.008105
582 DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 3 25 0.001015 0.008105
583 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.001015 0.008105
584 CARDIOCYTE DIFFERENTIATION 5 96 0.001047 0.008345
585 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 197 0.001061 0.008425
586 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 7 197 0.001061 0.008425
587 REGULATION OF JAK STAT CASCADE 6 144 0.001073 0.00849
588 REGULATION OF STAT CASCADE 6 144 0.001073 0.00849
589 RESPONSE TO BACTERIUM 12 528 0.001137 0.00897
590 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 3 26 0.001141 0.00897
591 NEGATIVE REGULATION OF LIPID TRANSPORT 3 26 0.001141 0.00897
592 REGULATION OF P38MAPK CASCADE 3 26 0.001141 0.00897
593 NEGATIVE REGULATION OF SECRETION 7 200 0.001158 0.009087
594 CELLULAR RESPONSE TO CYTOKINE STIMULUS 13 606 0.0012 0.009403
595 DIGESTIVE SYSTEM DEVELOPMENT 6 148 0.001236 0.00963
596 POSITIVE REGULATION OF CELL GROWTH 6 148 0.001236 0.00963
597 MALE SEX DIFFERENTIATION 6 148 0.001236 0.00963
598 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 3 27 0.001276 0.009882
599 RESPONSE TO LITHIUM ION 3 27 0.001276 0.009882
600 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 3 27 0.001276 0.009882
601 SUBSTRATE DEPENDENT CELL MIGRATION 3 27 0.001276 0.009882
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 22 76 8.348e-29 7.755e-26
2 RECEPTOR BINDING 57 1476 7.264e-25 3.374e-22
3 COLLAGEN BINDING 16 65 6.053e-20 1.125e-17
4 EXTRACELLULAR MATRIX BINDING 15 51 4.482e-20 1.125e-17
5 GLYCOSAMINOGLYCAN BINDING 23 205 5.412e-20 1.125e-17
6 INTEGRIN BINDING 17 105 8.474e-18 1.312e-15
7 HEPARIN BINDING 19 157 2.627e-17 3.487e-15
8 SULFUR COMPOUND BINDING 21 234 2.502e-16 2.906e-14
9 CELL ADHESION MOLECULE BINDING 19 186 6.496e-16 6.705e-14
10 FIBRONECTIN BINDING 10 28 9.371e-15 8.705e-13
11 PROTEIN COMPLEX BINDING 35 935 1.335e-14 1.128e-12
12 GROWTH FACTOR BINDING 15 123 6.025e-14 4.665e-12
13 CYTOKINE ACTIVITY 17 219 2.169e-12 1.55e-10
14 STRUCTURAL MOLECULE ACTIVITY 28 732 5.177e-12 3.435e-10
15 CALCIUM ION BINDING 27 697 9.778e-12 6.056e-10
16 MACROMOLECULAR COMPLEX BINDING 38 1399 1.647e-11 9.561e-10
17 PLATELET DERIVED GROWTH FACTOR BINDING 6 11 1.066e-10 5.828e-09
18 GROWTH FACTOR ACTIVITY 13 160 5.351e-10 2.762e-08
19 CYTOKINE RECEPTOR BINDING 16 271 5.893e-10 2.881e-08
20 PEPTIDASE REGULATOR ACTIVITY 13 214 1.842e-08 8.556e-07
21 INSULIN LIKE GROWTH FACTOR BINDING 6 25 3.726e-08 1.648e-06
22 CHEMOATTRACTANT ACTIVITY 6 27 6.147e-08 2.596e-06
23 SMAD BINDING 8 72 1.091e-07 4.408e-06
24 GLYCOPROTEIN BINDING 9 101 1.193e-07 4.618e-06
25 PROTEASE BINDING 9 104 1.538e-07 5.715e-06
26 ENZYME REGULATOR ACTIVITY 24 959 6.74e-07 2.408e-05
27 MOLECULAR FUNCTION REGULATOR 29 1353 9.947e-07 3.3e-05
28 GROWTH FACTOR RECEPTOR BINDING 9 129 9.678e-07 3.3e-05
29 VIRUS RECEPTOR ACTIVITY 7 70 1.444e-06 4.626e-05
30 LAMININ BINDING 5 30 3.731e-06 0.0001155
31 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 4 15 5.027e-06 0.0001507
32 CYTOKINE BINDING 7 92 9.11e-06 0.0002645
33 SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 7 95 1.126e-05 0.0003171
34 PEPTIDASE INHIBITOR ACTIVITY 9 177 1.303e-05 0.0003559
35 ACTIN BINDING 13 393 1.729e-05 0.0004589
36 ENZYME INHIBITOR ACTIVITY 12 378 5.467e-05 0.001411
37 PROTEOGLYCAN BINDING 4 30 9.192e-05 0.002308
38 WNT PROTEIN BINDING 4 31 0.0001049 0.002564
39 PROTEIN DOMAIN SPECIFIC BINDING 15 624 0.000151 0.003596
40 METALLOENDOPEPTIDASE INHIBITOR ACTIVITY 3 14 0.0001714 0.003981
41 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 3 15 0.000213 0.004827
42 PEPTIDASE ACTIVATOR ACTIVITY 4 38 0.0002356 0.005089
43 CORECEPTOR ACTIVITY 4 38 0.0002356 0.005089
44 TRANSFORMING GROWTH FACTOR BETA BINDING 3 16 0.0002607 0.005264
45 RECEPTOR AGONIST ACTIVITY 3 16 0.0002607 0.005264
46 CXCR CHEMOKINE RECEPTOR BINDING 3 16 0.0002607 0.005264
47 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 3 19 0.0004431 0.008759
48 RECEPTOR REGULATOR ACTIVITY 4 45 0.0004553 0.008812
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 63 426 1.835e-63 1.072e-60
2 PROTEINACEOUS EXTRACELLULAR MATRIX 58 356 1.224e-60 3.574e-58
3 EXTRACELLULAR MATRIX COMPONENT 37 125 1.267e-48 2.466e-46
4 EXTRACELLULAR SPACE 70 1376 5.209e-39 7.604e-37
5 BASEMENT MEMBRANE 24 93 5.393e-30 6.299e-28
6 COMPLEX OF COLLAGEN TRIMERS 13 23 3.574e-22 3.478e-20
7 COLLAGEN TRIMER 17 88 3.558e-19 2.968e-17
8 CELL SUBSTRATE JUNCTION 26 398 1.344e-16 9.812e-15
9 ANCHORING JUNCTION 28 489 2.426e-16 1.574e-14
10 ENDOPLASMIC RETICULUM LUMEN 19 201 2.757e-15 1.61e-13
11 BANDED COLLAGEN FIBRIL 8 12 6.775e-15 3.597e-13
12 CELL SURFACE 32 757 7.824e-15 3.808e-13
13 INTRACELLULAR VESICLE 39 1259 1.396e-13 6.273e-12
14 PLATELET ALPHA GRANULE 12 75 7.661e-13 3.196e-11
15 SECRETORY GRANULE 19 352 6.112e-11 2.379e-09
16 PLATELET ALPHA GRANULE LUMEN 9 55 4.969e-10 1.814e-08
17 SECRETORY VESICLE 20 461 8.77e-10 2.85e-08
18 VESICLE LUMEN 11 106 8.785e-10 2.85e-08
19 SECRETORY GRANULE LUMEN 10 85 1.513e-09 4.65e-08
20 GOLGI LUMEN 10 94 4.111e-09 1.2e-07
21 EXTERNAL SIDE OF PLASMA MEMBRANE 14 238 7.705e-09 2.143e-07
22 CELL JUNCTION 30 1151 8.621e-09 2.288e-07
23 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 6 30 1.209e-07 3.069e-06
24 ENDOPLASMIC RETICULUM PART 28 1163 1.536e-07 3.739e-06
25 SIDE OF MEMBRANE 16 428 3.562e-07 8.32e-06
26 FILAMENTOUS ACTIN 5 20 4.33e-07 9.727e-06
27 LYSOSOMAL LUMEN 8 88 5.26e-07 1.138e-05
28 CYTOPLASMIC VESICLE PART 18 601 1.607e-06 3.352e-05
29 PLASMA MEMBRANE PROTEIN COMPLEX 16 510 3.51e-06 7.069e-05
30 VACUOLAR LUMEN 8 115 4.033e-06 7.852e-05
31 ENDOPLASMIC RETICULUM 31 1631 4.916e-06 9.261e-05
32 GOLGI APPARATUS 28 1445 1.075e-05 0.0001961
33 RECEPTOR COMPLEX 12 327 1.325e-05 0.0002344
34 INTRINSIC COMPONENT OF PLASMA MEMBRANE 30 1649 1.685e-05 0.0002893
35 BASAL LAMINA 4 21 2.123e-05 0.0003351
36 GLYCOPROTEIN COMPLEX 4 21 2.123e-05 0.0003351
37 ACTIN FILAMENT 6 70 2.05e-05 0.0003351
38 MEMBRANE REGION 23 1134 3.625e-05 0.0005572
39 SARCOLEMMA 7 125 6.654e-05 0.0009963
40 PLASMA MEMBRANE RECEPTOR COMPLEX 8 175 8.443e-05 0.001233
41 GOLGI APPARATUS PART 19 893 9.851e-05 0.001403
42 CELL LEADING EDGE 11 350 0.0001228 0.001707
43 INTERSTITIAL MATRIX 3 14 0.0001714 0.002328
44 ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT 6 105 2e-04 0.002654
45 ANCHORED COMPONENT OF MEMBRANE 7 152 0.0002254 0.002925
46 CONTRACTILE FIBER 8 211 0.0003045 0.003866
47 LAMELLIPODIUM MEMBRANE 3 19 0.0004431 0.005506
48 RUFFLE MEMBRANE 5 80 0.0004563 0.005552
49 PLASMA MEMBRANE REGION 18 929 0.00047 0.005602
50 LEADING EDGE MEMBRANE 6 134 0.0007377 0.008616

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04512_ECM.receptor_interaction 27 85 1.82e-36 3.276e-34
2 hsa04510_Focal_adhesion 30 200 9.672e-30 8.705e-28
3 hsa04151_PI3K_AKT_signaling_pathway 25 351 7.202e-17 4.321e-15
4 hsa04974_Protein_digestion_and_absorption 12 81 1.99e-12 8.957e-11
5 hsa04810_Regulation_of_actin_cytoskeleton 11 214 1.254e-06 4.514e-05
6 hsa04640_Hematopoietic_cell_lineage 7 88 6.78e-06 0.0002034
7 hsa04115_p53_signaling_pathway 6 69 1.887e-05 0.0004852
8 hsa04145_Phagosome 8 156 3.749e-05 0.0008436
9 hsa04350_TGF.beta_signaling_pathway 6 85 6.196e-05 0.001239
10 hsa04390_Hippo_signaling_pathway 7 154 0.0002442 0.004395
11 hsa04010_MAPK_signaling_pathway 9 268 0.0003158 0.005168
12 hsa04672_Intestinal_immune_network_for_IgA_production 4 49 0.0006316 0.009474
13 hsa04514_Cell_adhesion_molecules_.CAMs. 6 136 0.0007972 0.01104
14 hsa04310_Wnt_signaling_pathway 6 151 0.001369 0.01761
15 hsa04670_Leukocyte_transendothelial_migration 4 117 0.01455 0.1746
16 hsa04610_Complement_and_coagulation_cascades 3 69 0.01791 0.2015
17 hsa04110_Cell_cycle 4 128 0.01959 0.2074
18 hsa04014_Ras_signaling_pathway 5 236 0.04144 0.4144
19 hsa04912_GnRH_signaling_pathway 3 101 0.04744 0.4166
20 hsa00310_Lysine_degradation 2 44 0.04834 0.4166
21 hsa04620_Toll.like_receptor_signaling_pathway 3 102 0.0486 0.4166
22 hsa00480_Glutathione_metabolism 2 50 0.0607 0.4966
23 hsa04150_mTOR_signaling_pathway 2 52 0.06503 0.509
24 hsa04340_Hedgehog_signaling_pathway 2 56 0.074 0.555
25 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.08097 0.5764
26 hsa04380_Osteoclast_differentiation 3 128 0.08343 0.5764
27 hsa04360_Axon_guidance 3 130 0.08646 0.5764
28 hsa04260_Cardiac_muscle_contraction 2 77 0.1264 0.7925
29 hsa04012_ErbB_signaling_pathway 2 87 0.1538 0.9225
30 hsa04540_Gap_junction 2 90 0.1622 0.9416
31 hsa04020_Calcium_signaling_pathway 3 177 0.1692 0.9515
32 hsa04062_Chemokine_signaling_pathway 3 189 0.1931 0.9681
33 hsa04916_Melanogenesis 2 101 0.1936 0.9681
34 hsa04270_Vascular_smooth_muscle_contraction 2 116 0.2376 1
35 hsa04722_Neurotrophin_signaling_pathway 2 127 0.2702 1
36 hsa04630_Jak.STAT_signaling_pathway 2 155 0.3524 1
37 hsa04144_Endocytosis 2 203 0.4846 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 HCG11 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-362-3p;hsa-miR-618;hsa-miR-93-5p 13 SGCD Sponge network -0.781 0 -2.197 0 0.582
2 RP11-12A2.3 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-30d-5p;hsa-miR-338-3p;hsa-miR-339-5p;hsa-miR-501-3p 12 TGFBR3 Sponge network -4.779 0 -1.535 0 0.524
3 RP11-54O7.3 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-148a-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-362-3p;hsa-miR-618 10 SGCD Sponge network -3.012 0 -2.197 0 0.519
4 CTC-444N24.11 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 1.087 0 1.182 0 0.49
5 RP11-43F13.3 hsa-miR-107;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-548b-3p;hsa-miR-93-5p 10 SGCD Sponge network -1.507 0.01021 -2.197 0 0.475
6 LINC00665 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 2.394 0 1.182 0 0.469
7 LINC01018 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-423-5p;hsa-miR-589-3p 12 TGFBR3 Sponge network -3.231 0 -1.535 0 0.466
8 RP11-119D9.1 hsa-let-7d-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-501-3p 10 TGFBR3 Sponge network -2.765 0 -1.535 0 0.465
9 MIR4435-1HG hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 2.541 0 2.535 0 0.45
10 RP11-747H7.3 hsa-miR-101-5p;hsa-miR-1269a;hsa-miR-192-3p;hsa-miR-192-5p;hsa-miR-193b-3p;hsa-miR-28-5p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-34a-5p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-616-5p;hsa-miR-618 14 QSOX1 Sponge network 0.351 0.40524 -0.998 0.00035 0.44
11 MAGI2-AS3 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-362-3p;hsa-miR-532-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-93-5p 14 SGCD Sponge network -1.801 0 -2.197 0 0.435
12 LINC00924 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-93-5p 11 SGCD Sponge network -0.391 0.1281 -2.197 0 0.43
13

SNHG1

 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 2.013 0 1.182 0 0.42
14

HCG18

 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 1.42 0 1.182 0 0.417
15 MAPKAPK5-AS1 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-33a-3p 10 SPOCK1 Sponge network 1.411 0 2.535 0 0.397
16 LINC00152 hsa-miR-130a-3p;hsa-miR-139-5p;hsa-miR-195-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-326;hsa-miR-3607-3p;hsa-miR-497-5p 10 ITGA2 Sponge network 2.553 0 1.531 0 0.382
17

RP5-1120P11.1

 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 3.942 0 1.182 0 0.382
18 RP11-290F5.1 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-423-5p 10 TGFBR3 Sponge network -1.679 5.0E-5 -1.535 0 0.378
19

HCG18

 hsa-miR-130a-3p;hsa-miR-139-5p;hsa-miR-195-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-30e-5p;hsa-miR-326;hsa-miR-33a-3p;hsa-miR-3607-3p;hsa-miR-497-5p 10 ITGA2 Sponge network 1.42 0 1.531 0 0.369
20

SNHG1

 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 11 SPOCK1 Sponge network 2.013 0 2.535 0 0.362
21 RP11-166D19.1 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-532-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-618;hsa-miR-92a-3p 12 SGCD Sponge network -0.244 0.28835 -2.197 0 0.348
22 GUSBP11 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 2.066 0 2.535 0 0.343
23 KB-1572G7.2 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 2.124 0 2.535 0 0.342
24

SNHG12

 hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 10 SPOCK1 Sponge network 1.791 0 2.535 0 0.327
25

SNHG12

 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 1.791 0 1.182 0 0.323
26 RP11-611E13.2 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 1.148 0 2.535 0 0.323
27 MIR497HG hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-3682-3p;hsa-miR-532-5p;hsa-miR-93-5p 11 SGCD Sponge network -0.886 0.00689 -2.197 0 0.32
28 RP11-89K21.1 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-497-5p 10 LAMC1 Sponge network 4.915 0 1.182 0 0.319
29

SOCS2-AS1

 hsa-miR-106b-5p;hsa-miR-146b-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-484;hsa-miR-532-5p;hsa-miR-769-3p;hsa-miR-93-5p 10 DST Sponge network -0.984 3.0E-5 -0.376 0.00155 0.316
30

RP5-1120P11.1

 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 10 SPOCK1 Sponge network 3.942 0 2.535 0 0.314
31 RP11-600F24.7 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 2.603 0 2.535 0 0.312
32 AP001258.4 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-33a-3p 10 SPOCK1 Sponge network 1.249 0 2.535 0 0.303
33 ZFAS1 hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-193b-3p;hsa-miR-195-5p;hsa-miR-22-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-7-1-3p 10 LAMC1 Sponge network 1.155 0 1.182 0 0.295
34 RP1-228H13.5 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 11 SPOCK1 Sponge network 1.554 0 2.535 0 0.292
35 RP11-196G18.22 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-33a-3p 10 SPOCK1 Sponge network 2.705 0 2.535 0 0.289
36

HCG18

 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 11 SPOCK1 Sponge network 1.42 0 2.535 0 0.283
37 AC159540.1 hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-618 10 SPOCK1 Sponge network 2.112 0 2.535 0 0.28
38 GS1-124K5.11 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-326;hsa-miR-33a-3p 10 SPOCK1 Sponge network 1.5 0 2.535 0 0.278
39 DLGAP1-AS2 hsa-let-7f-1-3p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326 10 SPOCK1 Sponge network 1.357 0 2.535 0 0.274
40 AC005154.6 hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-193a-5p;hsa-miR-22-3p;hsa-miR-23b-3p;hsa-miR-23b-5p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-326;hsa-miR-33a-3p 10 SPOCK1 Sponge network 1.75 0 2.535 0 0.272

Quest ID: 67c44c525671f7fb913564db45d92231